Difference between revisions of "Pietanza MC, et al. Lung Cancer (2016) cited as Ref 224 in DOI: 10.1038/s41392-020-0110-5 (Q9487)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 99, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): A phase I trial of the Hedgehog inhibitor sonidegib (LDE225) in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer, #quickstatements; #temporary_b...) |
||
Property / title | |||
+ | A phase I trial of the Hedgehog inhibitor sonidegib (LDE225) in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer (English) | ||
Property / title: A phase I trial of the Hedgehog inhibitor sonidegib (LDE225) in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer (English) / rank | |||
+ | Normal rank |
Revision as of 21:55, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Pietanza MC, et al. Lung Cancer (2016) cited as Ref 224 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Pietanza MC
0 references
2016
0 references
Lung Cancer
0 references
99
0 references
A phase I trial of the Hedgehog inhibitor sonidegib (LDE225) in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer (English)
0 references